H.C. Wainwright & Co. Initiates Coverage on atai Life Sciences, With Buy Rating And US$40 Price Target
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.